Notably, the anti-diabetic effect is not secondary to weight loss, and the mechanisms and specific neuronal circuits by which FGF1 induce diabetes remission remains to be fully determined but likely involves the HPA axis (Perry et al., 2015). The gene discussed is FGF1; the disease is diabetes mellitus.